RE-TREATMENT VS CHANGE THERAPY IN FIRST RELAPSE: POST-HOC ANALYSIS OF 476 PATIENTS WITH MULTIPLE MYELOMA (MM) INCLUDED IN TWO PROSPECTIVE TRIALS

被引：0
|
作者：
Offidani, M. [1 ]
Corvatta, L. [2 ]
Bringhen, S. [3 ]
Gentili, S. [1 ]
Gay, F. [3 ]
Maracci, L. [1 ]
Ciccone, G. [4 ,5 ]
Boccadoro, M. [3 ]
Leoni, P. [1 ]
Palumbo, A. [3 ]
机构：
[1] AOU Osped Riuniti Ancona, Clin Ematol, Ancona, Italy
[2] UOC Med, Fabriano, Italy
[3] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy
[4] AOU Citta Salute & Sci Torino, Unit Clin Epidemiol, Turin, Italy
[5] CPO Piemonte, Turin, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1274
引用
收藏
页码：511 / 511
页数：1
相关论文
共 32 条
  • [1] REAL WORLD EXPERIENCE OF BORTEZOMIB RE-TREATMENT FOR PATIENTS WITH MULTIPLE MYELOMA AT FIRST RELAPSE
    Reyal, Y.
    Popat, R.
    Cheesman, S.
    Rismani, A.
    D'Sa, S.
    Rabin, N.
    Yong, K.
    HAEMATOLOGICA, 2016, 101 : 803 - 803
  • [2] Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse
    Reyal, Yasmin
    Popat, Rakesh
    Cheesman, Simon
    Rismani, Ali
    D'Sa, Shirley
    Rabin, Neil
    Yong, Kwee
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (03) : 495 - 497
  • [3] Maintenance Therapy vs Re-treatment at Biochemical Relapse vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II, Randomized Study
    Mina, Roberto
    Larocca, Alessandra
    Belotti, Angelo
    Conticello, Concetta
    Monaco, Federico
    Offidani, Massimo
    Ronconi, Sonia
    Marchetti, Monia
    Ria, Roberto
    Mosca-Siez, Maria Letizia
    Pescosta, Norbert
    Grasso, Mariella
    Capra, Andrea
    Zambello, Renato
    Poggiu, Marco
    Giuliani, Nicola
    Ballanti, Stelvio
    Cellini, Claudia
    Liberati, Anna Marina
    Siniscalchi, Agostina
    Petrucci, Maria Teresa
    Palumbo, Antonio
    Musto, Pellegrino
    Sonneveld, Pieter
    Boccadoro, Mario
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E271 - E271
  • [4] MAINTENANCE THERAPY vs RE-TREATMENT AT BIOCHEMICAL RELAPSE vs OBSERVATION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS: RESULTS OF A PHASE II, RANDOMIZED STUDY
    Mina, R.
    Larocca, A.
    Belotti, A.
    Conticello, C.
    Monaco, F.
    Offidani, M.
    Ronconi, S.
    Marchetti, M.
    Ria, R.
    Conconi, A.
    Pescosta, N.
    Grasso, M.
    Capra, A.
    Zambello, R.
    Poggiu, M.
    Giuliani, N.
    Ballanti, S.
    Cellini, C.
    Liberati, A. M.
    Caravita, T.
    Petrucci, M. T.
    Palumbo, A.
    Musto, P.
    Sonneveld, P.
    Boccadoro, M.
    HAEMATOLOGICA, 2019, 104 : 69 - 70
  • [5] MAINTENANCE THERAPY WITH LENALIDOMIDE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST-HOC ANALYSIS OF THE EMN01 TRIAL
    Magarotto, V.
    Bringhen, S.
    Offidani, M.
    Benevolo, G.
    Patriarca, F.
    Palladino, C.
    Falcone, A. P.
    Rossi, D.
    Villani, O.
    Musolino, C.
    Conticello, C.
    Pulini, S.
    Omede, P.
    Zambello, R.
    Guglielmelli, T.
    Ledda, A.
    Liberati, A. M.
    Hajek, R.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA, 2015, 100 : 82 - 82
  • [6] Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials
    Hiroyasu Yamamoto
    Takashi Yamada
    Ken Miyazaki
    Takuto Yamashita
    Takuya Kato
    Kenichi Ohara
    Yusuke Nakamura
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2023, 27 : 651 - 659
  • [7] Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials
    Yamamoto, Hiroyasu
    Yamada, Takashi
    Miyazaki, Ken
    Yamashita, Takuto
    Kato, Takuya
    Ohara, Kenichi
    Nakamura, Yusuke
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (08) : 651 - 659
  • [8] Bortezomib-Dexamethasone Re-Treatment at Biochemical Relapse Vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II Multi-Center, Randomized Study
    Mina, Roberto
    Larocca, Alessandra
    Belotti, Angelo
    Di Raimondo, Francesco
    Baraldi, Anna
    Offidani, Massimo
    Marchetti, Monia
    Ria, Roberto
    Conconi, Annarita
    Pescosta, Norbert
    Grasso, Mariella
    Cetani, Giusy
    Cafro, Anna Maria
    Passera, Roberto
    Troia, Rossella
    Semenzato, Gianpietro
    Giuliani, Nicola
    Ballanti, Stelvio
    Cellini, Claudia
    Liberati, Anna Marina
    Di Toritto, Tommaso Caravita
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Palumbo, Antonio
    Sonneveld, Pieter
    Boccadoro, Mario
    BLOOD, 2017, 130
  • [9] Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse
    Cohen, Oliver C.
    Counsell, Nicholas
    Rabin, Neil
    Popat, Rakesh
    Owen, Roger G.
    Popova, Bilyana
    Schofield, Oliver
    Clifton-Hadley, Laura
    Lyons-Lewis, Janet
    Rawstron, Andy
    Spence, Christopher
    de Tute, Ruth M.
    Hughes, Derralynn
    Moore, Sally
    Smith, Paul
    Yong, Kwee L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 948 - 951
  • [10] Pre-Endovascular Therapy Change in BP is Associated With Outcome: A post-Hoc Analysis of the Blood Pressure After Endovascular Treatment (BEST) Prospective Cohort Study
    Mistry, Eva
    Dakay, Karatina
    Peterson, Nils
    Jayaraman, Mahesh
    McTaggart, Ryan
    Furie, Karen
    Mehta, Tapan
    Arora, Niraj
    Starosciak, Amy
    La Rosa, De Los Rios Felipe
    Siegler, James, III
    Barnhill, Natasha
    Mistry, Akshitkumar
    Patel, Kishan
    Assad, Salman
    Tarboosh, Amjad
    Wagner, Jeff
    Bennett, Alicia
    Cruz, Aurora
    Fortuny, Enzo
    James, Robert
    Jagadeesan, Bharathi
    Streib, Christopher
    Weber, Stewart
    Kasner, Scott
    Chitale, Rohan
    Volpi, John
    Mayer, Stephan
    Khatri, Pooja
    Yaghi, Shadi
    STROKE, 2019, 50
1234